Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Zenith wins Nexium

Published on .

AstraZeneca, Westborough, Mass., awarded an estimated $40 million in media buying and planning for new indigestion drug Nexium to Zenith Media, New York. Nexium is the pharmaceutical company's successor to Prilosec. Zenith competed with three other New York shops: Creative Media, SFM Media/ MPG and Initiative Media North America. "Nexium needed credible strategic planning skills and network horsepower to get quick visibility in the market,'' said an executive close to the review.

Copyright April 2000, Crain Communications Inc.

Most Popular
In this article: